Abstract:Background
Water avoidance stress (WAS) induces a naloxone‐independent visceral analgesia in male rats under non‐invasive conditions of monitoring. The objective of the study was to examine the role of brain CRF signaling in acute stress‐induced visceral analgesia (SIVA).
Methods
Adult male Sprague‐Dawley rats were chronically implanted with an intracerebroventricular (ICV) cannula. The visceromotor response (VMR) to graded phasic colorectal distension (CRD: 10, 20, 40, 60 mm Hg, 20 seconds, 4 minutes interval… Show more
“…The 4V chronically cannulated rats were divided into 7 groups ( 4 showing maximal efficiency to influence gastrointestinal function and prevent CRF action. [30][31][32] Fecal pellets and diarrhea were monitored for 1 h after the last injection, then rats were euthanized by decapitation, the colon was harvested for whole-mount preparation of pC and dC enteric plexus followed by immunohistochemistry.…”
Background: Hypothalamic corticotropin-releasing factor (CRF) receptor 1 (CRF 1 ) plays a role in acute stress-related stimulation of colonic motor function. Less is known on CRF 1 signaling in the brainstem.
Methods:We investigate CRF 1 expression in the brainstem and the colonic response to 4 th ventricle (4V) injection of CRF and urocortin (Ucn) 2 (3 µg/rat) in chronically cannulated male rats. Key results: Transcripts of CRF 1 wild-type 1a and splice variants 1c, 1e, 1f, 1o along with three novel variants 1a-2 (desK-110 in exon 5), 1p (-exon 7), and 1q (exon 5 extension) were identified in the pons and medulla. The area postrema, nucleus tractus solitarius, dorsal motor nucleus of the vagus, locus coeruleus, and Barrington's nucleus isolated by laser capture microdissection expressed 1a, 1a-2, and 1p but not 1q. Compared to 4V vehicle, 4V CRF induced fecal pellet output (FPO) and diarrhea that were blocked by the CRF antagonist, astressin-B. CRF 2 agonist, Ucn2 had no effect on basal or CRF-induced FPO. CRF actions were correlated with the induction of c-Fos immunoreactivity in myenteric neurons of the proximal and distal colon (pC, dC) and submucosal neurons of dC. c-Fos immunoreactivity occurred in 39% and 37% of myenteric cholinergic and 7% and 58% of nitrergic neurons in the pC and dC, respectively.Conclusions & Inferences: CRF 1a and its splice variants are expressed in brainstem nuclei, and activation of CRF 1 signaling at the level of the brainstem stimulates colonic secretory-motor function through activation of colonic enteric neurons.
“…The 4V chronically cannulated rats were divided into 7 groups ( 4 showing maximal efficiency to influence gastrointestinal function and prevent CRF action. [30][31][32] Fecal pellets and diarrhea were monitored for 1 h after the last injection, then rats were euthanized by decapitation, the colon was harvested for whole-mount preparation of pC and dC enteric plexus followed by immunohistochemistry.…”
Background: Hypothalamic corticotropin-releasing factor (CRF) receptor 1 (CRF 1 ) plays a role in acute stress-related stimulation of colonic motor function. Less is known on CRF 1 signaling in the brainstem.
Methods:We investigate CRF 1 expression in the brainstem and the colonic response to 4 th ventricle (4V) injection of CRF and urocortin (Ucn) 2 (3 µg/rat) in chronically cannulated male rats. Key results: Transcripts of CRF 1 wild-type 1a and splice variants 1c, 1e, 1f, 1o along with three novel variants 1a-2 (desK-110 in exon 5), 1p (-exon 7), and 1q (exon 5 extension) were identified in the pons and medulla. The area postrema, nucleus tractus solitarius, dorsal motor nucleus of the vagus, locus coeruleus, and Barrington's nucleus isolated by laser capture microdissection expressed 1a, 1a-2, and 1p but not 1q. Compared to 4V vehicle, 4V CRF induced fecal pellet output (FPO) and diarrhea that were blocked by the CRF antagonist, astressin-B. CRF 2 agonist, Ucn2 had no effect on basal or CRF-induced FPO. CRF actions were correlated with the induction of c-Fos immunoreactivity in myenteric neurons of the proximal and distal colon (pC, dC) and submucosal neurons of dC. c-Fos immunoreactivity occurred in 39% and 37% of myenteric cholinergic and 7% and 58% of nitrergic neurons in the pC and dC, respectively.Conclusions & Inferences: CRF 1a and its splice variants are expressed in brainstem nuclei, and activation of CRF 1 signaling at the level of the brainstem stimulates colonic secretory-motor function through activation of colonic enteric neurons.
“…Many studies support an important role for stress in the IBS pathophysiology and symptoms ( 8 ). The stress-induced activation or augmentation of the CRF and HPA axis systems has been associated with visceral hypersensitivity, an important feature of IBS, in animal models ( 55 – 58 ). IBS patients have a greater reactivity to stress compared to healthy subjects, as manifested by a dysregulated HPA axis response, enhanced visceral perception and gut motility, among other findings ( 59 – 61 ).…”
Section: Stress: An Environmental Trigger For Ibsmentioning
Irritable bowel syndrome (IBS) is a brain-gut axis disorder characterized by abdominal pain and altered bowel habits. IBS is a multifactorial, stress-sensitive disorder with evidence for familial clustering attributed to genetic or shared environmental factors. However, there are weak genetic associations reported with IBS and a lack of evidence to suggest that major genetic factor(s) contribute to IBS pathophysiology. Studies on animal models of stress, including early life stress, suggest a role for environmental factors, specifically, stress associated with dysregulation of corticotropin releasing factor and hypothalamuspituitary-adrenal (HPA) axis pathways in the pathophysiology of IBS. Recent evidence suggests that epigenetic mechanisms, which constitute molecular changes not driven by a change in gene sequence, can mediate environmental effects on central and peripheral function. Epigenetic alterations including DNA methylation changes, histone modifications, and differential expression of non-coding RNAs (microRNA [miRNA] and long non-coding RNA) have been associated with several diseases. The objective of this review is to elucidate the molecular factors in the pathophysiology of IBS with an emphasis on epigenetic mechanisms. Emerging evidence for epigenetic changes in IBS includes changes in DNA methylation in animal models of IBS and patients with IBS, and various miRNAs that have been associated with IBS and endophenotypes, such as increased visceral sensitivity and intestinal permeability. DNA methylation, in particular, is an emerging field in the realm of complex diseases and a promising mechanism which can provide important insights into IBS pathogenesis and identify potential targets for treatment.
“…In addition to somatic pain, CRF seems to intervene in the regulation of visceral pain [ 8 ]. Indeed, intracerebroventricular administration of CRF resulted in a significant inhibition of the nociceptive visceromotor response to colorectal distension [ 9 ]. Moreover, systemic application of a CRF-R2 agonist inhibited an increase in the spinal activity marker ERK1/2 and prevented a nociceptive visceromotor response to colorectal distension [ 10 ].…”
Corticotropin-releasing factor (CRF) orchestrates our body’s response to stressful stimuli. Pain is often stressful and counterbalanced by activation of CRF receptors along the nociceptive pathway, although the involvement of the CRF receptor subtypes 1 and/or 2 (CRF-R1 and CRF-R2, respectively) in CRF-induced analgesia remains controversial. Thus, the aim of the present study was to examine CRF-R1 and CRF-R2 expression within the spinal cord of rats with Freund’s complete adjuvant-induced unilateral inflammation of the hind paw using reverse transcriptase polymerase chain reaction, Western blot, radioligand binding, and immunofluorescence confocal analysis. Moreover, the antinociceptive effects of intrathecal (i.t.) CRF were measured by paw pressure algesiometer and their possible antagonism by selective antagonists for CRF-R1 and/or CRF-R2 as well as for opioid receptors. Our results demonstrated a preference for the expression of CRF-R2 over CRF-R1 mRNA, protein, binding sites and immunoreactivity in the dorsal horn of the rat spinal cord. Consistently, CRF as well as CRF-R2 agonists elicited potent dose-dependent antinociceptive effects which were antagonized by the i.t. CRF-R2 selective antagonist K41498, but not by the CRF-R1 selective antagonist NBI35965. In addition, i.t. applied opioid antagonist naloxone dose-dependently abolished the i.t. CRF- as well as CRF-R2 agonist-elicited inhibition of somatic pain. Importantly, double immunofluorescence confocal microscopy of the spinal dorsal horn showed CRF-R2 on enkephalin (ENK)-containing inhibitory interneurons in close opposition of incoming mu-opioid receptor-immunoreactive nociceptive neurons. CRF-R2 was, however, not seen on pre- or on postsynaptic sensory neurons of the spinal cord. Taken together, these findings suggest that i.t. CRF or CRF-R2 agonists inhibit somatic inflammatory pain predominantly through CRF-R2 receptors located on spinal enkephalinergic inhibitory interneurons which finally results in endogenous opioid-mediated pain inhibition.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.